2011, Number 6
<< Back Next >>
Gac Med Mex 2011; 147 (6)
Deep sweet syndrome as a cause or Fever of Unknown Origin. A case report and literature review
Mancheno-Valencia A, Káram-Orantes M, Arrazola-Guerrero J, Hajar-Serviansky T, Ochoa-Sánchez P, Rosas-Manzano A, Sánchez-Armendáriz K, Zepeda-López P, Vega-Memije ME, Toussaint-Caire S, Rodríguez-Carreón AA
Language: Spanish
References: 36
Page: 541-544
PDF size: 615.25 Kb.
ABSTRACT
Sweet syndrome is the prototype of neutrophilic dermatosis, which typically presents an intense inflammatory infiltrate of neutrophils in the epidermis and/or dermis, apparently due to a hypersensitivity reaction.
This is a case of a 31 year-old woman with fever of more than three weeks duration and erythematous nudosities on her arms and legs. The histological study of a skin lesion showed a lobular inflammatory infiltrate of lymphocytes and neutrophils, with excellent response to prednisone. Therefore, it was concluded as subcutaneous sweet syndrome.
REFERENCES
Sweet RD. An acute febrile neutrophilicdermatoses. Br J Dermatol. 1964;76:349.
Sweet RD. Acute febrile neutrophilicdermatosis. Br J Dermatol. 1979;100:93-9.
Callen JP. Neutrophilicdermatoses. Dermatol Clin. 2002;20:409.
Lamar-Morales Y, Carballar-Alberteries L, Arteaga-Hernández E, Medell- Gago M, Alfonso-Trujillo I. Síndrome de Sweet paniculítico. Dermatol Perú. 2009;19(4):344-9.
Wallach D, Vignon-Pennamen MD. From acute febrile neutrophilicdermatosis to neutrophilic disease: Forty years of clinical research. J Am Acad Dermatol. 2006;55:1066-71.
Cohen P. Sweet’s syndrome-a comprehensive review of an acute febrile neutrophilicdermatosis. Orphanet J Rare Dis. 2007;2:34.
Cohen PR, Kurzrock R. Sweet’s syndromes a neutrophilicdermatosis classically associated with acute onset and fever. Clin Dermatol. 2000;18(3):265-82.
Ribeiro A, Costa J, Bogas M, Costa L, Araújo D. Acute febrile neutrophilic dermatosis - Sweet’s syndrome. Acta Reumatol Port. 2009;34: 536-40.
Chiba S. Sweet’s syndrome with neurologic signs and psychiatric symptoms. Arch Neurol.1983;40:829.
Cohen PR, Hönigsmann H, Kurzrock R. Sweet’s syndrome. Orphanet Encyclopedia. 2003. Disponible en: http:// www.orpha.net/data/patho/GB/uk-Sweet.pdf
Wolff K. Sweet´s syndrome. Wolff K, Goldsmith L, Katz S, Gilchrest B, Paller A, Leffell D (Eds). En: Fitzpatrick´s: Dermatology in General Medicine. 7th Edition. Nueva York: McGraw-Hill Inc.; 2008. p. 289-95.
Cohen PR, Holder WR, Rapini RP. Concurrent Sweet’s syndrome and erythema nodosum: a report, world literature review and mechanism of pathogenesis. J Rheumatol.1992;19:814-20.
Tuerlinckx D, Bodart E, Despontin K, Boutsen Y, Godding V, Ninane J. Sweet’s syndrome with arthritis in a 8-month-old boy. J Rheumatol. 1999;26:440-2.
Kawakami T, Ohashi S, Kawa Y, et al. Elevated serum granulocyte colony-stimulatingfactor levels in patients with active phase of Sweet syndromeand patients with activeBehcet disease: implication in neutrophil apoptosis dysfunction. Arch Dermatol. 2004;140:570-4.
Shinojima Y, Toma Y, Terui T. Sweet syndrome associated with intrahepatic cholangiocarcinoma producing granulocyte colony-stimulating factor. Br J Dermatol. 2006;154:1103-4.
Oiso N, Watanabe K, Kawada A. Granulocyte colony-stimulating factorinduced Sweet syndrome in a healthy donor. Br J Haematol. 2006;135:148.
Pimienta M, Olivé A. El fenómeno de patergia. Semin Fund Esp Reumatol. 2009;10(3):87-90.
Corazza M, Lauriola MM, Borghi A, Marzola A, Virgili A. Sweet’s syndrome: A retrospective clinical, histopathological and immunohistochemical analysis of 11 cases. Acta Derm Venereol. 2008;88:601-6.
Sitjas D, Puig L, Cuatrecasas M, De Moragas JM. Acute febrile neutrophilicdermatosis (Sweet’s syndrome). Int J Dermatol. 1993;32:261-8.
Miller RM, Darben TA, Nedwich J, Savige J. Propylthiouracilinduced antineutrophil cytoplasmic antibodies in a patient with Graves’ disease and a neutrophilicdermatosis. Br J Dermatol. 1999;141:931-55.
Sutra-Loubet C, Carlotti A, Guillemette J, Wallach D. Neutrophilic lobular panniculitis. J Am Acad Dermatol. 2004;50:280-5.
Teng JM, Draper BK, Boyd AS. Sweet’s panniculitis associated with metastatic breast cancer. J Am Acad Dermatol. 2007;56:S61-2.
Neoh CY, Tan AW, Ng SK. Sweet’s syndrome: a spectrum of unusual clinical presentations and associations. Br J Dermatol. 2007; 156:480-5.
Barksdale S, Barnhill R. Vasculitis and related disorders. En: Dermatopathology. Crowson N, Magro C, Piepkorn M (Eds). 3rd Edition. Nueva York: McGraw-Hill Inc.; 2010. p. 188-9.
Von den Driesch P. Sweet’s syndrome (acute febrile neutrophilicdermatosis). J Am Acad Dermatol. 1994;31:535-60.
Walker DC, Cohen PR. Trimethoprim-sulfamethoxazole-associated acute febrile neutrophilicdermatosis: case report and review of drug-induced Sweet’s syndrome. J Am Acad Dermatol. 1996;34:918-23.
Prajapati V, Barankin B. Sweet syndrome. Dermacase. Can Fam Physician. 2008;54:1249-52.
Haverstock C, Libecco JF, Sadeghi P, Maytin E. Tender erythematous plaques in a woman with acute myelogenous leukemia. Arch Dermatol. 2006;142:235-40.
Disel U, Paydas S, Yavuz S, Tuncer I, Alpay R. Bilateral ear Sweet’s syndrome in a case with relapse acute myeloblastic leukemia. Leuk Res. 2006;30:364.
Cohen PR, Kurzrock R. Sweet’s syndrome revisited: a review of disease concepts. Int J Dermatol. 2003;42:761-78.
Shimizu T, Yoshida I, Eguchi H, et al. Sweet syndrome in a child with aplastic anemia receivingrecombinant granulocyte colony-stimulating factor. J Pediatr Hematol Oncol. 1996;18:282-4.
Sáez M, García-Bustínduy M, Noda A, et al. Drug induced Sweet’s syndrome. J Eur Acad Dermatol Venereol. 2004;18:233.
Del Giudice P, Vandenbos F, Perrin C, Bernard E, Marq L, Dellamonica P. Sweet’s syndrome following abacavir therapy. J Am Acad Dermatol. 2004;51:474-5.
Gyorfy A, Kovács T, Szegedi I, Oláh E, Kiss C. Sweet’s syndrome associated with 13-cis-retinoic acid (isotretinoin) therapy. Med Pediatr Oncol. 2003;40:135-6.
Govindarajan G, Bashir Q, Kuppuswamy S, Brooks C. Sweet syndrome associated with furosemide. South Med J. 2005;98:570-2.
White JM, Mufti GJ, Salisbury JR, Du Vivier AW. Cutaneous manifestations of granulocyte colony-stimulating factor. Clin Exp Dermatol. 2006;31:206-7.